Loading
Model Medicines
Model Medicines is transforming drug discovery by leveraging the historical compendium of drug development data and unbiased AI to create Phase II/III ready drug candidates in days rather than decades.
Funding
Every round, secondary, debt facility or acquisition involving Model Medicines that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—